Related Party Transactions

12 Months Ended

Dec. 31, 2013

Related Party Transaction, Due from (to) Related Party [Abstract]

Related Party Transactions

Related Party Transactions

Shell and Raízen

As discussed in Note 3, “Collaborative Research and Development Agreements,” Shell transferred full ownership of the Company's common stock to Raízen, Shell’s joint venture with Cosan S.A., ("Cosan"), in Brazil, in June 2011. Upon Shell’s transfer of ownership interest to Raízen in 2011, Raízen owned 5.6 million shares of the Company's common stock. In July 2011, the Company appointed Pedro Mizutani to the Board of Directors. Mr. Mizutani also serves as the Chief Operating Officer of Raízen S.A. and other affiliated companies as well as a director of Cosan. There were no related party transactions with either Raízen or Cosan for the years ended December 31, 2013, 2012 and 2011.

Exela PharmaSci, Inc.

The Company signed a license agreement with Exela PharmaSci, Inc. (“Exela”) in 2007. A member of the Company's board of directors is also on the board of directors of Exela. Under the terms of the agreement, Exela agreed to pay to the Company a contractual percentage share of Exela’s net profit from the sales of licensed products.

During the years ended December 31, 2013, 2012 and 2011, the Company recognized $4,631,000, $150,000 and $450,000 of revenue, respectively, related to this arrangement, shown in the Company's consolidated statement of operations as revenue sharing arrangement. As of December 31, 2013, the Company had $445,000 owed from Exela and as of December 31, 2012, the Company had no receivables from Exela.

Alexander A. Karsner

Alexander A. Karsner is a director of Codexis and provided consulting services to the Company during 2011, 2012 and 2013. Mr. Karsner was paid $120,000 for consulting services for the year ended December 31, 2013 and there was no amount owed as of December 31, 2013.